| Product Code: ETC8370723 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mongolia Neuraminidase Inhibitors Market Overview |
3.1 Mongolia Country Macro Economic Indicators |
3.2 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Mongolia Neuraminidase Inhibitors Market - Industry Life Cycle |
3.4 Mongolia Neuraminidase Inhibitors Market - Porter's Five Forces |
3.5 Mongolia Neuraminidase Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Mongolia Neuraminidase Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Mongolia Neuraminidase Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Mongolia Neuraminidase Inhibitors Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Mongolia Neuraminidase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mongolia Neuraminidase Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of neuraminidase inhibitors in treating influenza |
4.2.2 Rising prevalence of influenza outbreaks in Mongolia |
4.2.3 Government initiatives to improve healthcare infrastructure and accessibility in the country |
4.3 Market Restraints |
4.3.1 High cost associated with neuraminidase inhibitors |
4.3.2 Limited availability and access to advanced healthcare facilities in rural areas of Mongolia |
4.3.3 Potential side effects and safety concerns related to neuraminidase inhibitors |
5 Mongolia Neuraminidase Inhibitors Market Trends |
6 Mongolia Neuraminidase Inhibitors Market, By Types |
6.1 Mongolia Neuraminidase Inhibitors Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type A, 2021- 2031F |
6.1.4 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type B, 2021- 2031F |
6.1.5 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mongolia Neuraminidase Inhibitors Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Zanamivir, 2021- 2031F |
6.2.3 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Oseltamivir, 2021- 2031F |
6.2.4 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Peramivir, 2021- 2031F |
6.2.5 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Laninamivir, 2021- 2031F |
6.2.6 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Mongolia Neuraminidase Inhibitors Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Inhalation, 2021- 2031F |
6.3.4 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.5 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mongolia Neuraminidase Inhibitors Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Mongolia Neuraminidase Inhibitors Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Mongolia Neuraminidase Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Mongolia Neuraminidase Inhibitors Market Import-Export Trade Statistics |
7.1 Mongolia Neuraminidase Inhibitors Market Export to Major Countries |
7.2 Mongolia Neuraminidase Inhibitors Market Imports from Major Countries |
8 Mongolia Neuraminidase Inhibitors Market Key Performance Indicators |
8.1 Number of healthcare facilities offering neuraminidase inhibitors in Mongolia |
8.2 Patient adherence rate to neuraminidase inhibitors treatment |
8.3 Number of reported influenza cases in Mongolia |
9 Mongolia Neuraminidase Inhibitors Market - Opportunity Assessment |
9.1 Mongolia Neuraminidase Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Mongolia Neuraminidase Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Mongolia Neuraminidase Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Mongolia Neuraminidase Inhibitors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Mongolia Neuraminidase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mongolia Neuraminidase Inhibitors Market - Competitive Landscape |
10.1 Mongolia Neuraminidase Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Mongolia Neuraminidase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here